Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease

European Journal of Neuroscience

Volumn 27, Issue 1, 2008, Pages 43-52

  Quinn, M ^a   Mukhida, K ^a   Sadi, D ^a   Hong, M ^a   Mendez, I ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Dopamine; Mechanical trauma; Parkinsonian; Rat; Transplantation

Indexed keywords

NONIONIC SURFACTANT; POLOXAMER; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; FETUS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; REINNERVATION;

AMPHETAMINE; ANALYSIS OF VARIANCE; ANIMALS; BEHAVIOR, ANIMAL; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; EMBRYO, MAMMALIAN; FEMALE; MESENCEPHALON; NERVE FIBERS; NEURONS; OXIDOPAMINE; PARKINSON DISEASE; POLOXAMER; RATS; SURFACE-ACTIVE AGENTS; TIME FACTORS; TYROSINE 3-MONOOXYGENASE;

EID: 37749001050     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05991.x     Document Type: Article

References (58)

1. Apostolides, C., Sanford, E., Hong, M. Mendez, I. (1998) Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience, 83, 363 372.
2. Barker, R.A., Dunnet, S.B., Faissner, A. Fawcett, J.W. (1996) The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesecephalon to the striatum. Exp. Neurol., 141, 79 93.
3. Barnéoud, P., Descombris, E., Aubin, N. Abrous, D.N. (2000) Evaluation of simple and complex sensorimotor behaviours in rats with a partial lesion of the dopaminergic nigrostriatal system. Eur. J. Neurosci., 12, 322 326.
4. Bartlett, L., Sadi, D., Lewington, M. Mendez, I. (2004) Functional improvement with low-dose dopaminergic grafts in hemiparkinsonian rats. Neurosurgery, 55, 405 415.
5. Borgens, R.B., Bohnert, D., Duerstock, B., Spomar, D. Lee, R.C. (2004) Subcutaneous tri-block copolymer produces recovery from spinal cord injury. J. Neurosci. Res., 76, 141 154.
6. Brundin, P., Karlsson, J., Emgard, M., Schierle, G.S.K., Hansson, O., Petersen, A. Castilho, R.F. (2000) Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant., 9, 179 195.
7. Cadichon, S.B., Le Hoang, M., Wright, D.A., Curry, D.J., Kang, U. Frim, D.M. (2007) Neuroprotective effect of the surfactant poloxamer 188 in a model of intracranial hemorrhage in rats. J. Neurosurg., 106 (1 Suppl. 36 40.
8. Cicchetti, F., Costantini, L., Belizaire, R., Burton, W., Isacson, O. Fodor, W. (2002) Combined inhibition of apoptosis and complement improves neural graft survival of embryonic rat and porcine mesencephalon in the rat brain. Exp. Neurol., 177, 376 384.
9. Curry, D.J., Wright, D.A., Lee, R.C., Kang, U.J. Frim, D.M. (2004) Surfactant poloxamer 188-related decreases in inflammation and tissue damage after experimental brain injury in rats. J. Neurosurg., 101 (1 Suppl. 91 96.
10. Emgard, M., Karlsson, J., Hansson, O. Brundin, P. (1999) Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts. Exp. Neurol., 160, 279 288.
11. Emgard, M., Blomgren, K. Brundin, P. (2002) Characterization of cell damage and death in embryonic mesencephliac tissue: a study on ultrastructural, vital stains and protease activity. Neuroscience, 115, 1177 1187.
12. Emgard, M., Hallin, U., Karlsson, J., Bahr, B.A., Brundin, P. Blomgren, K. (2003) Both apoptosis and necrosis occur early after intracerebral grafting of ventral mesencephalic tissue: a role for protease activation. J. Neurochem., 86, 1223 1232.
13. Espejo, M., Cutillas, B., Arenas, T.E. Ambrosio, S. (2000) Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor. Cell Transplant., 9, 45 53.
14. Forman, M.B., Ingram, D.A. Murray, J.J. (1992) Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury. Am. Heart J., 124, 1347 1357.
15. Freed, C.R., Greene, P.E., Breeze, R.R., Tsai, W.Y., DuMouchel, W., Kao, R., Dillon, D., Winfield, H., Culver, S., Trojanowski, J.Q., Eidelberg, D. Faun, S. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med., 344, 710 719.
16. Frim, D.M., Wright, D.A., Curry, D.J., Cromie, W., Lee, R. Kang, U.J. (2004) The surfactant poloxamer-188 protects against glutamate toxicity in the rat brain. Neuroreport, 15, 171 174.
17. Gundersen, H.J.G. Jensen, E.B. (1987) The efficiency of systematic sampling in stereology and its prediction. J. Microsc., 147, 229 263.
18. Haque, N.S., Du Hlavin, M.L.J.S., Fawcett, J.W. Dunnett, S.B. (1995) In vivo effects of kFGF on embryonic nigral grafts in a rat model of Parkinson's disease. Neuroreport, 13, 2177 2181.
19. Haque, N.S., Hlavin, M.L., Fawcett, J.W. Dunnett, S.B. (1996) The neurotrophin NT4/5, but not NT3, enhances the efficacy of nigral grafts in a rat model of Parkinson's disease. Brain Res., 712, 45 52.
20. Hebb, A.O., Hebb, K., Ramachandran, A.C. Mendez, I. (2003) Glial cell line-derived neurotrophic factor-supplemented hibernation of fetal ventral mesencephalic neurons for transplantation in Parkinson's disease: long-term storage. J. Neurosurg., 98, 1078 1083.
21. Kaminski-Schierle, G.S., Hansson, O. Brundin, P. (1999) Flunarizine improves the survival of grafted dopaminergic neurons. Neuroscience, 94, 17 20.
22. Kirik, D., Georgievska, B., Rosenblad, C. Björklund, A. (2001) Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease. Eur. J. Neurosci., 13, 1589 1599.
23. Kordower, J.H., Freeman, T.B., Chen, E.Y., Mufson, E.J., Sanberg, P.R., Hauser, R.A., Snow, B. Olanow, C.W. (1998) Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease. Mov. Disord., 13, 383 393.
24. Laverty, P.H., Leskovar, A., Breur, G.J., Coates, J.R., Bergman, R.L., Widmer, W.R., Toombs, J.P., Shapiro, S. Borgens, R.B. (2004) A preliminary study of intravenous surfactants in paraplegic dogs: polymer therapy in canine clinical SCI. J. Neurotrauma, 21, 1767 1777.
25. Lee, R.C., River, P., Pan, F.S., Ji, L. Wollmann, R.L. (1992) Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo. Proc. Natl Acad. Sci. U.S.A., 89, 4524 4528.
26. Marks, J.D., Pan, C.Y., Bushell, T., Cromie, W. Lee, R.C. (2001) Amphiphilic, tri-block copolymers provide potent membrane-targeted neuroprotection. FASEB J., 15, 1107 1109.
27. Maskarinec, S.A., Hannig, J., Lee, R.C. Lee, K.Y.C. (2002) Direct observation of poloxamer 188 insertion into lipid monolayers. Biophys. J., 82, 1453 1459.
28. McIntosh, T.K., Juhler, M. Wieloch, T. (1998) Novel pharmacological strategies in the treatment of experimental traumatic brain injury. J. Neurotrauma, 15, 731 769.
29. Mehta, V., Hong, M., Spears, J. Mendez, I. (1998) Enhancement of graft survival and sensorimotor behavioural recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J. Neurosurg., 88, 1088 1095.
30. Mendez, I., Sadi, D. Hong, M. (1996) Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J. Neurosci., 16, 7216 7227.
31. Mendez, I., Dagher, A., Hong, M., Hebb, A., Gaudet, P. Law, A. (2000) Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line-derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations. J. Neurosurg., 92, 863 869.
32. Mendez, I., Dagher, A., Hong, M., Gaudet, P., Weerasinghe, S., McAlister, V., King, D., Desrosiers, D., Darvesh, S., Acorn, T. Robertson, H. (2002) Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson's disease: a pilot study. Report of three cases. J. Neurosurg., 96, 589 596.
33. Mendez, I., Sanchez-Pernaute, R., Cooper, O., Viñuela, A., Ferrari, D., Björklund, L., Dagher, A. Isacson, O. (2005) Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain, 128, 1498 1510. Epub 2005, May 4.
34. Merchant, F.A., Holmes, W.H., Capelli-Schellpfeffer, M., Lee, R.C. Toner, M. (1998) Poloxamer 188 enhances functional recovery of lethally heat-shocked fibroblasts. J. Surg. Res., 74, 131 140.
35. Meyer, M., Matarredona, E.R., Seiler, R.W., Zimmer, J. Widmer, H.R. (2001) Additive effect of glial cell line-derived neurotrophic factor and neurotrophin 4/5 on rat fetal nigral explant cultures. Neuroscience, 108, 273 284.
36. Nakao, N., Frodl, E.M., Duan, W.M., Widner, H. Brundin, P. (1994) Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl Acad. Sci. U.S.A., 91, 12 408 12 412.
37. Nikkhah, G., Olsson, M., Eberhard, J., Bentlage, C., Cunningham, M.G. Björklund, A. (1994) A microtransplantation approach cell suspension grafting in the rat Parkinson model. A detailed account of the methodology. Neuroscience, 63, 57 72.
38. Olanow, C.W., Goetz, C.G., Kordower, J.H., Stoessl, A.J., Sossi, V., Brin, M.F., Shannon, K.M., Nauert, G.M., Perl, D.P., Godbold, J. Freeman, T.B. (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol., 54, 403 414.
39. Padanilam, J.T., Bischof, J.C., Lee, R.C., Cravalho, E.G., Tompkins, R.G., Yarmush, M.L. Toner, M. (1994) Effectiveness of poloxamer 188 in arresting calcein leakage from thermally damaged isolated skeletal muscle cells. Ann. N.Y. Acad. Sci., 720, 111 123.
40. Rafuse, V.R., Soundararajan, P., Leopold, C. Robertson, H.A. (2005) Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog. Neuroscience, 131, 899 916.
41. Raghupathi, R., Graham, D.I. McIntosh, T.K. (2002) Apoptosis after traumatic brain injury. J. Neurotrauma, 17, 927 938.
42. Rioux, L., Gaudin, D.P., Bui, L.K., Gregoire, L., DiPaolo, T. Bedard, P.J. (1991) Correlation of functional recovery after a 6-hydroxydopamine lesion with survival of grafted fetal neurons and release of dopamine in the striatum of the rat. Neuroscience, 40, 123 131.
43. Rosenblad, C., Martinez-Serrano, A. Björklund, A. (1996) Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience, 75, 979 985.
44. Rosenblad, C., Kirik, D. Björklund, A. (1999) Neurturin enhances the survival of intrastriatal fetal dopaminergic transplants. Neuroreport, 10, 1783 1787.
45. Sauer, H. Brundin, P. (1991) Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor. Neurol. Neurosci., 2, 123 135.
46. Sautter, J., Höglinger, G.U., Oertel, W.H. Earl, C.D. (2000) Systemic treatment with GM1 ganglioside improves survival and function of cryopreserved embryonic midbrain grafted to the 6-hydroxydopamine-lesioned rat striatum. Exp. Neurol., 164, 121 129.
47. Schierle, G.S. Brundin, P. (1998) Excitotoxicity plays a role in the death of tyrosine hydroxylase-immunopositive nigral neurons cultured in serum-free medium. Exp. Neurol., 157, 338 348.
48. Schierle, G.S., Hansson, O., Leist, M., Nicotera, P., Widner, H. Brundin, P. (1999) Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med., 5, 97 100.
49. Serbest, G., Horwitz, J., Jost, M. Barbee, K. (2006) Mechanisms of cell death and neuroprotection by poloxamer 188 after mechanical trauma. FASEB J., 20, 308 310.
50. Sharma, V., Stebe, K., Murphy, J.C. Tung, L. (1996) Poloxamer 188 decreases susceptibility of artificial lipid monolayers to electroporation. Biophys. J., 71, 3229 3241.
51. Sortwell, C.E., Pitzar, M.R. Collier, T.J. (2000) Time course of apoptotic cell death within mesencephalic cell suspension grafts: Implications for improving grafted dopamine neuron survival. Exp. Neurol., 165, 268 277.
52. Sortwell, C.E., Camargo, M.D., Pitzer, M.R., Gyawali, S. Collier, T.J. (2001) Diminished survival of mesencephalic dopamine neurons grafted into aged hosts occurs during the immediate postgrafting interval. Exp. Neurol., 169, 23 29.
53. Winkler, C., Kirik, D. Björklund, A. (2005) Cell transplantation in Parkinson's disease: how can we make it work? Trends Neurosci., 28, 86 92.
54. Wu, G., Majewski, J., Ege, C., Kjaer, K., Weygand, M.J. Lee, K.Y. (2005) Interaction between lipid monolayers and poloxamer 188: an X-ray reflectivity and diffraction study. Biophys. J., 89, 3159 3173. Epub 2005, August 12.
55. Young, W. (1993) Secondary injury mechanisms in acute spinal cord injury. J. Emerg. Med., 11, 13 22.
56. Yurek, D.M., Lu, W., Hipkens, S. Wiegand, S.J. (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol., 137, 105 118.
57. Zawada, W.M., Zastrow, D.J., Clarksson, E.D., Adams, E.D., Adams, F.S., Bell, K.P. Freed, C.R. (1998) Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res., 786, 96 103.
58. Zawada, W.M., Meinter, M.K., Rao, P., Marotti, J., Wang, X., Esplen, J.E., Clarkson, D.E., Freed, C.R. Heidenreich, K.A. (2001) Inhibitors of p38 MAP kinase increase the survival of transplanted dopamine neurons. Brain Res., 891, 185 196.